Antios Therapeutics and Arbutus Biopharma Announce First Patient Dosed in Phase 2a Combination Trial of ATI-2173, AB-729 and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B Virus InfectionGlobeNewsWire • 12/14/21
Arbutus and Qilu Pharmaceutical Enter into an Exclusive Licensing Agreement and Strategic Partnership to Develop and Commercialize AB-729 in mainland China, Hong Kong, Macau and TaiwanGlobeNewsWire • 12/13/21
Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License AgreementGlobeNewsWire • 12/07/21
Implied Volatility Surging for Arbutus Biopharma (ABUS) Stock OptionsZacks Investment Research • 12/03/21
Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenueBusiness Insider • 12/01/21
ABUS Stock Alert: The Moderna News That Has Arbutus Biopharma Shares Rocketing TodayInvestorPlace • 12/01/21
Preliminary Data Shows that Arbutus' Capsid Inhibitor, AB-836 is Generally Safe and Well-Tolerated and Provides Robust Antiviral ActivityGlobeNewsWire • 12/01/21
Arbutus Shares Are Soaring As Moderna Loses Appeal Of Board Ruling On COVID-19 Vaccine Delivery Technology PatentBenzinga • 12/01/21